Inverness Stock Offering Proceeds To Help Fund Integ Buy Set For December
This article was originally published in The Gray Sheet
Executive Summary
Net proceeds from blood glucose monitor device maker Inverness Medical Technology's $90 mil. secondary stock offering Nov. 21 will help fund the planned acquisition of Integ, set to close by year-end.